Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
44
NCT03844191
A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4
Phase: Phase 1
Role: Collaborator
Start: Feb 18, 2019
Completion: Dec 1, 2019